BVS.NASDAQBioventus INC

Form 4: Bioventus Inc. Executive Sells Shares to Cover Taxes After Stock Vesting

Sentiment:

SEC Form 4 Filing


Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 4,380 shares of Class A Common Stock to cover taxes upon the vesting of restricted stock units.

Summary

  • On February 18, 2025, Anthony D'Adamio, SVP & General Counsel of Bioventus Inc., sold 4,380 shares of Class A Common Stock.
  • The sale was executed at a price of $10.19 per share.
  • The transaction was made to cover taxes upon the vesting of restricted stock units on February 15, 2025.
  • The sale was conducted pursuant to a standing 10b5-1 instruction adopted on March 15, 2024.
  • Following the transaction, D'Adamio directly owns 118,178 shares of Bioventus Inc. Class A Common Stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (stock sale for tax purposes) by a company executive, which is neither particularly positive nor negative. The use of a 10b5-1 plan suggests the transaction was pre-planned and not based on any specific event.

Industry Context

Sales of shares by company executives are a common occurrence, often related to compensation and tax obligations. These transactions are closely monitored by investors for insights into management's perspective on the company's value and future prospects. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on insider information at the time of the transaction.

Stakeholder Impact

  • The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
  • The transaction does not directly impact employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2024-03-15Date of adoption of the standing 10b5-1 instruction.
2025-02-15Date of vesting of restricted stock units.
2025-02-18Date of the stock sale transaction.
2025-02-20Date of signature on the Form 4 filing.

Keywords

Form 4, Bioventus Inc., BVS, Anthony D'Adamio, SVP & General Counsel, Stock Sale, 10b5-1 Plan, Class A Common Stock, Restricted Stock Units, Tax Coverage

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.